US 7,390,488 B2
	Compositions and methods for producing vascular occlusion
Michael W. Stewart, St. Albert (Canada); Antoine Noujaim, Edmonton (Canada); and Roland H. Person, Edmonton (Canada)
Assigned to ViRexx Medical Corp., Edmonton, Alberta (Canada)
Filed on Aug. 17, 2005, as Appl. No. 11/205,045.
Application 11/205045 is a division of application No. 10/101731, filed on Mar. 21, 2002.
Application 10/101731 is a continuation of application No. 09/438944, filed on Nov. 12, 1999, granted, now 6,887,474.
Application 09/438944 is a continuation of application No. PCT/IB99/01809, filed on Nov. 10, 1999.
Claims priority of provisional application 60/108129, filed on Nov. 12, 1998.
Prior Publication US 2005/0287145 A1, Dec. 29, 2005
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/395 (2006.01); C07K 14/745 (2006.01); C07K 16/28 (2006.01)

U.S. Cl. 424—130.1  [424/178.1; 530/350; 530/380; 530/381; 530/387.1; 530/387.3; 530/388.1; 530/389.1]

14 Claims

1. A composition for inducing site-specific thrombus formation at a pre-determined site comprising a binding agent having a first binding component and a second binding component, said first binding component comprising a binding region for binding the binding agent to a pre-determined site; said second binding component comprising a binding region for binding platelets, whereby said binding agent, when bound by platelets, induces thrombus formation at said pre-determined site.